MY129714A - Preparations for topical administration of substances having antiandrogenic activity - Google Patents

Preparations for topical administration of substances having antiandrogenic activity

Info

Publication number
MY129714A
MY129714A MYPI20031577A MYPI20031577A MY129714A MY 129714 A MY129714 A MY 129714A MY PI20031577 A MYPI20031577 A MY PI20031577A MY PI20031577 A MYPI20031577 A MY PI20031577A MY 129714 A MY129714 A MY 129714A
Authority
MY
Malaysia
Prior art keywords
preparations
substances
topical administration
compound
formula
Prior art date
Application number
MYPI20031577A
Inventor
Karl Theodor Dr Kraemer
Karl-Heinz Dr Nietsch
Rainer Dr Pooth
Uwe Muenster
Wolfgang Dr Mehnert
Monika Prof Dr Schaefer-Korting
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MY129714A publication Critical patent/MY129714A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A PREPARATION COMPRISING AT LEAST ONE FORM OF LIPID NANOPARTICLES OR A NANOEMULSION COMPRISING AT LEAST ONE COMPOUND OF THE FORMULA 1:AND/OR ONE STEREOISOMERIC FORM OF THE COMPOUND OF THE FORMULA 1 AND/OR ONE PHYSIOLOGICALLY TOLERATED SALT OF THE COMPOUND OF THE FORMULA 1, IN WHICH R1 IS -(C5-C17)-ALKYL OR -(C5-C17)-ALKENYL, IS SUITABLE FOR THE TREATMENT OF ANDROGENIC ALOPECIA, OF HIRSUTISM, THAT IS TO SAY TO PREVENT UNWANTED HAIR GROWTH, AND FOR THE TREATMENT OF SEBORRHEA AND ANCE AND CAN FURTHERMORE BE EMPLOYED IN COSMETICS.
MYPI20031577A 2002-04-27 2003-04-25 Preparations for topical administration of substances having antiandrogenic activity MY129714A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10218963A DE10218963A1 (en) 2002-04-27 2002-04-27 Preparations for the topical application of antiandrogen active substances

Publications (1)

Publication Number Publication Date
MY129714A true MY129714A (en) 2007-04-30

Family

ID=29264882

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20031577A MY129714A (en) 2002-04-27 2003-04-25 Preparations for topical administration of substances having antiandrogenic activity

Country Status (17)

Country Link
EP (1) EP1501806B1 (en)
JP (1) JP4633459B2 (en)
AR (1) AR039662A1 (en)
AT (1) ATE321756T1 (en)
AU (1) AU2003229658B2 (en)
BR (1) BRPI0309579B8 (en)
CA (1) CA2483786C (en)
DE (2) DE10218963A1 (en)
DK (1) DK1501806T3 (en)
ES (1) ES2256735T3 (en)
IL (1) IL164814A0 (en)
MX (1) MXPA04009571A (en)
MY (1) MY129714A (en)
PE (1) PE20031044A1 (en)
PT (1) PT1501806E (en)
TW (1) TWI285637B (en)
WO (1) WO2003093243A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7271188B2 (en) 2003-06-12 2007-09-18 Chugai Seikayu Kabushiki Kaisha Imidazolidine derivatives
EP2299266A1 (en) 2003-12-19 2011-03-23 The Regents of the University of California Methods and materials for assessing prostate cancer therapies
CN100475781C (en) * 2004-02-13 2009-04-08 沃尼尔·朗伯有限责任公司 Androgen receptor modulators
CA2554696C (en) * 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
US7718684B2 (en) 2004-02-24 2010-05-18 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7507860B2 (en) 2004-04-13 2009-03-24 Pfizer Inc. Androgen modulators
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
CA2570047C (en) 2004-07-08 2010-09-28 Warner-Lambert Company Llc 4-cycloalkoxy benzonitriles as androgen modulators
CN101044131A (en) * 2004-08-31 2007-09-26 沃尼尔·朗伯有限责任公司 Androgen modulators
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
DK2656841T3 (en) 2006-03-27 2016-12-05 Univ California Androgen receptor MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND androgen receptor-ASSOCIATED DISEASES
RU2449993C2 (en) 2006-03-29 2012-05-10 Те Риджентс Оф Те Юниверсити Оф Калифорния Diarylthiohydatoic compounds
CA2966280A1 (en) 2007-10-26 2009-04-30 The Regents Of The University Of California Diarylhydantoin compounds
WO2011103202A2 (en) 2010-02-16 2011-08-25 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
RU2503446C2 (en) * 2012-02-07 2014-01-10 Алексей Валентинович Одинцов Hair growth product (versions) and methods of treating alopecia
KR20220025231A (en) 2012-09-26 2022-03-03 아라곤 파마슈티컬스, 인코포레이티드 Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL222631B1 (en) * 2012-11-14 2016-08-31 Gdański Univ Medyczny Pharmaceutical composition comprising Roxithromycin, method for manufacture and medical use of the composition and the medicinal product comprising a composition
WO2014078929A1 (en) * 2012-11-26 2014-05-30 Universidade Federal De Minas Gerais - Ufmg Topical formulation for the prevention and treatment of alopecia and for inhibiting hair growth
JOP20200097A1 (en) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc Androgen receptor modulator and uses thereof
CN103965112A (en) * 2014-05-13 2014-08-06 上海孚一生物科技有限公司 Compound with antiandrogen activity as well as preparation method and application of compound
TWI726969B (en) 2016-01-11 2021-05-11 比利時商健生藥品公司 Substituted thiohydantoin derivatives as androgen receptor antagonists
KR20200070334A (en) 2017-10-16 2020-06-17 아라곤 파마슈티컬스, 인코포레이티드 Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (en) * 1992-07-08 1994-09-02 Roussel Uclaf New substituted phenylimidazolidines, process for their preparation, their use as medicaments and the pharmaceutical compositions containing them.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2716110B1 (en) * 1994-02-16 1996-04-05 Roussel Uclaf Cosmetic or pharmaceutical compositions comprising liposomes.
AU726572B2 (en) * 1994-02-16 2000-11-09 Aventis Pharma S.A. Cosmetics or pharmaceutical compositions consisting of liposomes

Also Published As

Publication number Publication date
AU2003229658B2 (en) 2010-07-29
PT1501806E (en) 2006-06-30
DE10218963A1 (en) 2003-11-20
DE50302818D1 (en) 2006-05-18
AR039662A1 (en) 2005-03-02
CA2483786A1 (en) 2003-11-13
CA2483786C (en) 2011-08-09
ES2256735T3 (en) 2006-07-16
WO2003093243A1 (en) 2003-11-13
JP4633459B2 (en) 2011-02-16
BR0309579A (en) 2005-03-01
TW200407312A (en) 2004-05-16
DK1501806T3 (en) 2006-05-29
JP2005535584A (en) 2005-11-24
BR0309579B1 (en) 2014-10-07
ATE321756T1 (en) 2006-04-15
IL164814A0 (en) 2005-12-18
EP1501806B1 (en) 2006-03-29
PE20031044A1 (en) 2004-02-09
AU2003229658A1 (en) 2003-11-17
TWI285637B (en) 2007-08-21
BRPI0309579B8 (en) 2021-05-25
MXPA04009571A (en) 2005-01-11
EP1501806A1 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
MY129714A (en) Preparations for topical administration of substances having antiandrogenic activity
AU2004218468B2 (en) Method for increasing hair growth
WO2005000266A3 (en) Liposomal formulations comprising a combination of two or more active agents
KR20000076549A (en) A hair lotion with improved properties in its hair protecting action and prevention of hair loss, and the reduction of external effects of androgenic alopecia and resulting hair loss
WO2007113851A3 (en) Novel compositions for hair disorders and process of preparation thereof
JP2007514695A5 (en)
HK1032351A1 (en) Topical compositions for enhancing glutathione production.
DK1863430T3 (en) Composition based on vegetative extracts of Ajuga reptans for the prevention of hair loss, stimulation of hair growth, regulation of the production of sebum
IL111293A0 (en) Pharmaceutical compositions comprising 5 alpha-reductase type 2 inhibitor for treating androgenic alopecia
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
JP2004500353A5 (en)
IL142598A0 (en) Preparations for topical application of substances having antiandrogenic effect
AU2011100917A4 (en) Treatment of male and female androgenetic alopecia with oral minoxidil either alone or in combination with antiandrogens
KR20110045341A (en) Improvement composite of scalp and hair be contain yeast, gold, propolis, ginseng, purslane, clove, pleuropterus multiflorus
IL132625A (en) Composition for inducing hair growth
ES2137125A1 (en) Use of the zinc salt of glycyrrhetic acid in preparations against acne, and the compositions which contain said salt.
KR19990018331A (en) Hair growth promoting composition
WO2005009456A3 (en) Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment
EP1046392A3 (en) Cosmetic and dermatologic compositions for improving the skin barrier function
KR930703252A (en) Use of coucurbitin used in the manufacture of anti-allergic cosmetics or pharmaceutical, especially dermatological compositions, and methods of using the same
CA2625806A1 (en) Compositions for improving skin conditions comprising human growth hormone as an active ingredient
AR006605A1 (en) AN ANTIMICROBIAL HAIR TREATMENT COMPOSITION AND A METHOD FOR CARRYING OUT THE PREPARATION OF THE SAME.
EP2786747A1 (en) Promoting hair growth solution containing chlorine dioxide preparation method and use method thereof
KR101307304B1 (en) Composition for treating hair or scalp to prevent hair loss and promote growing hair
KR20090059230A (en) Cosmetic composition for anti-alopecia and trichogenousness